Xconomy’s Digital Events →
Flexion is developing treatments for osteoarthritis
Sponsored · Whitepaper
Virtual/hybrid trials and decentralized research can better integrate healthcare into patients’ lives and accelerate approval of new medications
Create well-controlled, biologically relevant test systems and validate them to support FDA approvals
With data from IBM Watson Health, epidemiologists can describe treatment patterns, persistence & adherence to therapy
© 2007-2021, Xconomy, Inc.
Xconomy is a registered service mark of Xconomy, Inc.
All rights reserved.